Abstract
In the curves shown elsewhere in this volume (see Chapter 15) for Stanford advanced stage follicular lymphoma patients, there is a small plateau at about 25%. However, with time this has decreased to less than 10%, and in fact the author saw one of these patients recently with a recurrence after 33 years. As physicians and medical oncologists, we focus on cure and freedom from relapse, but it is important to keep in mind that survival is really the most important parameter.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
The Non-Hodgkin’s Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin’s lymphomas: summary and description of a Working Formulation for clinical usage. Cancer 1982; 49: 2112–35.
Paryani SB, Hoppe RT, Cox RS, Colby TV, Kaplan HS. The role of radiation therapy in the management of stage III follicular lymphomas. J Clin Oncol 1984; 2: 841–8.
MacManus MP, Hoppe RT. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University. J Clin Oncol 1996;14: 1282–90.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag London
About this chapter
Cite this chapter
Horning, S.J. (1999). When to treat early stage follicular lymphoma. In: Mason, D.Y., Harris, N.L. (eds) Human Lymphoma: Clinical Implications of the REAL Classification. Springer, London. https://doi.org/10.1007/978-1-4471-0857-3_14
Download citation
DOI: https://doi.org/10.1007/978-1-4471-0857-3_14
Publisher Name: Springer, London
Print ISBN: 978-1-4471-1218-1
Online ISBN: 978-1-4471-0857-3
eBook Packages: Springer Book Archive